日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

DrugMap:半胱氨酸配体结合能力的泛癌定量分析

Mariko Takahashi ,Harrison B Chong ,Siwen Zhang ,Tzu-Yi Yang ,Matthew J Lazarov ,Stefan Harry ,Michelle Maynard ,Brendan Hilbert ,Ryan D White ,Heather E Murrey ,Chih-Chiang Tsou ,Kira Vordermark ,Jonathan Assaad ,Magdy Gohar ,Benedikt R Dürr ,Marianne Richter ,Himani Patel ,Gregory Kryukov ,Natasja Brooijmans ,Aliyu Sidi Omar Alghali ,Karla Rubio ,Antonio Villanueva ,Junbing Zhang ,Maolin Ge ,Farah Makram ,Hanna Griesshaber ,Drew Harrison ,Ann-Sophie Koglin ,Samuel Ojeda ,Barbara Karakyriakou ,Alexander Healy ,George Popoola ,Inbal Rachmin ,Neha Khandelwal ,Jason R Neil ,Pei-Chieh Tien ,Nicholas Chen ,Tobias Hosp ,Sanne van den Ouweland ,Toshiro Hara ,Lillian Bussema ,Rui Dong ,Lei Shi ,Martin Q Rasmussen ,Ana Carolina Domingues ,Aleigha Lawless ,Jacy Fang ,Satoshi Yoda ,Linh Phuong Nguyen ,Sarah Marie Reeves ,Farrah Nicole Wakefield ,Adam Acker ,Sarah Elizabeth Clark ,Taronish Dubash ,John Kastanos ,Eugene Oh ,David E Fisher ,Shyamala Maheswaran ,Daniel A Haber ,Genevieve M Boland ,Moshe Sade-Feldman ,Russell W Jenkins ,Aaron N Hata ,Nabeel M Bardeesy ,Mario L Suvà ,Brent R Martin ,Brian B Liau ,Christopher J Ott ,Miguel N Rivera ,Michael S Lawrence ,Liron Bar-Peled

TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma

TFE3 融合指导致癌转录程序,驱动 OXPHOS 并揭示易位性肾细胞癌的脆弱性

Jiao Li, Kaimeng Huang, Fiona McBride, Ananthan Sadagopan, Daniel S Gallant, Meha Thakur, Prateek Khanna, Bingchen Li, Maolin Ge, Cary N Weiss, Mingkee Achom, Qingru Xu, Kun Huang, Birgitta A Ryback, Miao Gui, Liron Bar-Peled, Srinivas R Viswanathan

NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer

NRF2激活诱导NADH还原应激,从而导致肺癌代谢脆弱性。

Tommy Weiss-Sadan ,Maolin Ge ,Makiko Hayashi ,Magdy Gohar ,Cong-Hui Yao ,Adriaan de Groot ,Stefan Harry ,Alexander Carlin ,Hannah Fischer ,Lei Shi ,Ting-Yu Wei ,Charles H Adelmann ,Konstantin Wolf ,Tristan Vornbäumen ,Benedikt R Dürr ,Mariko Takahashi ,Marianne Richter ,Junbing Zhang ,Tzu-Yi Yang ,Vindhya Vijay ,David E Fisher ,Aaron N Hata ,Marcia C Haigis ,Raul Mostoslavsky ,Nabeel Bardeesy ,Thales Papagiannakopoulos ,Liron Bar-Peled

A T-cell independent universal cellular therapy strategy through antigen depletion

通过抗原消耗实现的 T 细胞独立通用细胞治疗策略

Dan Li, Wenbing Wang, Shufeng Xie, Maolin Ge, Ruiheng Wang, Qiongyu Xu, Yan Sun, Jiang Zhu, Han Liu

Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance

调节多发性骨髓瘤中的蛋白酶体抑制剂耐受性:逆转不可避免的耐药性的替代策略

Maolin Ge #, Zhi Qiao #, Yan Kong #, Hongyu Liang #, Yan Sun, Hui Lu, Zhenshu Xu, Han Liu

Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemia

去泛素化酶抑制剂可减轻混合谱系白血病中细胞周期蛋白 A1 介导的蛋白酶体抑制剂耐受性

Maolin Ge, Qiongyu Xu, Ting Kang, Dan Li, Ruiheng Wang, Zhihong Chen, Shufeng Xie, Wenbin Wang, Han Liu

mTORC1-mediated amino acid signaling is critical for cell fate determination under transplant-induced stress

mTORC1 介导的氨基酸信号对于移植诱导应激下的细胞命运决定至关重要

Xiaoyan Cheng, Maolin Ge, Shouhai Zhu, Dan Li, Ruiheng Wang, Qiongyu Xu, Zhihong Chen, Shufeng Xie, Han Liu

Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors

恢复MLL可重新激活潜在的肿瘤抑制机制,使其更容易受到蛋白酶体抑制剂的攻击。

Maolin Ge # ,Dan Li # ,Zhi Qiao # ,Yan Sun # ,Ting Kang ,Shouhai Zhu ,Shifen Wang ,Hua Xiao ,Chunjun Zhao ,Shuhong Shen ,Zhenshu Xu ,Han Liu

Exosomes mediate intercellular transfer of non-autonomous tolerance to proteasome inhibitors in mixed-lineage leukemia

外泌体介导混合谱系白血病中对蛋白酶体抑制剂的非自主耐受性细胞间转移

Maolin Ge, Zhi Qiao, Yan Kong, Hui Lu, Han Liu

Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers

膜蛋白质组和微小RNA的综合分析揭示新的肺癌转移生物标志物

Yan Kong, Zhi Qiao, Yongyong Ren, Georgi Z Genchev, Maolin Ge, Hua Xiao, Hongyu Zhao, Hui Lu